SCHEMBL19269576

SCHEMBL19269576

C=C/C=C(\C=C)c1ccc(Nc2cccc3ccccc23)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDC25B P30305 2/20 0.53
▸ CYP3A4 P08684 2/20 0.53
▸ ALDH1A1 P00352 1/20 0.53
▸ TP53 P04637 1/20 0.53
▸ HPGD P15428 1/20 0.53
▸ ALOX15 P16050 1/20 0.53
▸ TSHR P16473 1/20 0.53
▸ ATM Q13315 1/20 0.53
▸ HSD17B10 Q99714 1/20 0.53
▸ RAB9A P51151 4/20 0.48
▸ FADS1 O60427 1/20 0.42
▸ KMT2A Q03164 4/20 0.41
▸ KDM4E B2RXH2 3/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ GAA P10253 2/20 0.41
▸ MAPT P10636 2/20 0.41
▸ GLA P06280 1/20 0.41
▸ RECQL P46063 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ POLB P06746 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29619354 0.76 HSD17B10 (0.87) CDC25BCYP3A4ALDH1A1TP53HPGD
SCHEMBL651572 0.76 HSD17B10 (0.87) CDC25BCYP3A4ALDH1A1TP53HPGD
SCHEMBL16500897 0.75 MAPK13 (0.40) ALDH1A1ALOX15TSHRHSD17B10RAB9A
SCHEMBL10110633 0.75 MAPK13 (0.40) ALDH1A1ALOX15TSHRHSD17B10RAB9A
SCHEMBL29050935 0.74 CDC25B (0.70) CDC25BCYP3A4ALDH1A1TP53HPGD
SCHEMBL6733723 0.74 HSD17B10 (0.65) CDC25BCYP3A4ALDH1A1TP53HPGD
SCHEMBL4593904 0.73 POLB (0.70) CDC25BCYP3A4ALDH1A1TP53HPGD
Propene SCHEMBL27671168 0.72 ALDH1A1 (0.79) CDC25BCYP3A4ALDH1A1TP53HPGD
SCHEMBL7954056 0.72 CDC25B (0.71) CDC25BCYP3A4ALDH1A1TP53HPGD
SCHEMBL7823629 0.72 ALDH1A1 (0.71) CDC25BCYP3A4ALDH1A1TP53HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10333073-B2 Compound for organic electric element, organic electric element using the same, and electronic device comprising same DUK SAN NEOLUX CO., LTD. (KR) 2019-06-25 — — US disclosed
US-20180033966-A1 NOVEL COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND ELECTRONIC DEVICE COMPRISING SAME DUK SAN NEOLUX CO., LTD. (KR) 2018-02-01 — — US disclosed
US-20180033966-A1 NOVEL COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND ELECTRONIC DEVICE COMPRISING SAME DUK SAN NEOLUX CO., LTD. (KR) 2018-02-01 — — US disclosed
US-20170244047-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE DUK SAN NEOLUX CO., LTD. (KR) 2017-08-24 — — US disclosed
US-20170244047-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE DUK SAN NEOLUX CO., LTD. (KR) 2017-08-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10333073-B2 Compound for organic electric element, organic electric element using the same, and electronic device comprising same EBPL, OR51E2, EML4 CDC25B 1855/4885CYP3A4 2462/4885ALDH1A1 1324/4885
US-20180033966-A1 NOVEL COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND ELECTRONIC DEVICE COMPRISING SAME EBPL, OR51E2, EML4 CDC25B 1694/4885CYP3A4 2766/4885ALDH1A1 1543/4885
US-20170244047-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE NFE2L2, LAGE3, OR51E2 CDC25B 2039/4885CYP3A4 770/4885ALDH1A1 832/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback